• Skip to navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

Marilyn Mann's Blog

  • Home
  • About
← 2013 Gina Kolata article on PKSK9 inhibitors was inaccurate
More data on alirocumab and diabetes risk →

Patient peer review

Jun 27

Posted by marilynmann

Amy Price and I wrote this blog post on being patient reviewers for The BMJ.

Share this:

  • Click to print (Opens in new window) Print
  • Click to email a link to a friend (Opens in new window) Email
  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • More
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Tumblr (Opens in new window) Tumblr
Like Loading...

Related

Posted on June 27, 2015, in health care, scholarly journals and tagged peer review, The BMJ. Bookmark the permalink. Leave a comment.

← 2013 Gina Kolata article on PKSK9 inhibitors was inaccurate
More data on alirocumab and diabetes risk →
  • Leave a comment

  • Comments 0

Leave a comment Cancel reply

  • StatCounter

    wordpress counter
  • Follow me on Twitter

    My Tweets
  • Recent posts

    • Funding for C3FIT Trial Approved by PCORI
    • Talk at QCOR 2018
    • Talk at CVCT 2017
    • Salim Yusuf on nutrition and cardiovascular disease
    • LDL-Lowering Genetic Variants Linked to Increased Risk of Diabetes
    • Diminishing returns in medical therapy
    • More data on alirocumab and diabetes risk
    • Patient peer review
    • 2013 Gina Kolata article on PKSK9 inhibitors was inaccurate
    • Do PCSK9 inhibitors affect diabetes risk?
    • Thoughts on the recent PCSK9 inhibitor studies
    • Advertising LVADs
    • IMPROVE-IT trial
    • National Physicians Alliance conference
    • American Heart Association journal announces new Patient Viewpoints
    • Input needed on stent decision aid
    • Making health care more patient-centered
    • My new Walking Gallery jacket
    • Assessment 2020 blog
    • New series of articles in Circulation: Cardiovascular Quality and Outcomes
  • Archives

  • Enter your email address to subscribe to this blog and receive notifications of new posts by email.

    Join 1,241 other subscribers
  • Search

    • Recent Comments
    • Popular Posts
    • Archives
    • Tags
    • Categories
    • Pierre Mercer's avatarPierre MercerThank you ffor sharing this
    • Pratik UX Designer's avatarPratik UX DesignerHelllo mate great blog post
    • Danielle Owen's avatarDanielle OwenHello mate greeat blog
    • More data on alirocumab and diabetes risk | Marilyn Mann's Blog[…] I happened to see an abstract from the American Heart Association Scientific Sessions in w
    • marilynmann's avatarmarilynmannMy friend Laura Newman was having trouble commenting so she emailed me this comment: "Excellent post
    • Cardiology Drugs Of The Year: New, Old, And Not-So-Funny | VantageWire[…] Old Drug Of The Year LCZ696 represents the future of cardiology. Ezetimibe, by contrast, r
    • marilynmann's avatarmarilynmannAlso, please check out this post on the Medical Professionalism Blog: http://blog.abimfoundation.org
    • marilynmann's avatarmarilynmannThere are a number of comments on the two versions of the decision aid over on the e-patients.net bl
    • Assessment 2020 blog (79)
    • Heart and Stroke Foundation “make death wait” campaign: effective advocacy or unnecessary scare tactics? (10)
    • Abbott Laboratories sponsors review article on its own drug (9)
    • More on the need for data sharing — the Tamiflu example (7)
    • Hayward and Krumholz: Open Letter to the Adult Treatment Panel IV of the National Institutes of Health (7)
    • Data sharing as a moral imperative (5)
    • Sunday links (5)
    • FDA warns Chantix may increase risk of cardiovascular events (4)
    • Profile on Harlan Krumholz (3)
    • Why the new indication for Vytorin and Zetia should not be approved (3)
    • September 2018 (1)
    • April 2018 (1)
    • December 2017 (1)
    • February 2017 (1)
    • October 2016 (1)
    • June 2016 (1)
    • December 2015 (1)
    • June 2015 (2)
    • May 2015 (1)
    • March 2015 (1)
    • January 2015 (1)
    • December 2014 (1)
    • November 2014 (1)
    • August 2014 (2)
    • April 2014 (2)
    • March 2014 (1)
    • February 2014 (1)
    • December 2013 (1)
    • September 2013 (1)
    • October 2012 (4)
    • September 2012 (1)
    • August 2012 (1)
    • July 2012 (1)
    • June 2012 (1)
    • May 2012 (4)
    • April 2012 (5)
    • March 2012 (2)
    • February 2012 (2)
    • January 2012 (2)
    • December 2011 (1)
    • November 2011 (2)
    • September 2011 (3)
    • August 2011 (1)
    • July 2011 (4)
    • June 2011 (3)
    • May 2011 (1)
    • February 2011 (1)
    • November 2010 (1)
    • October 2010 (3)
    • May 2010 (1)
    alirocumab American Heart Association Avandia blood glucose cardiology cardiovascular risk cholesterol Circulation: Cardiovascular Quality and Outcomes conflicts of interest Consumer Reports data sharing Dean Follmann diabetes drug safety EBM Ellis Unger evolocumab ezetimibe familial hypercholesterolemia Harlan Krumholz health care costs heart attacks heart disease hypertension Joseph Ross Merck Meridia Milton Packer open science PCSK9 inhibitors Peter Doshi publication bias Rodney Hayward rofecoxib Sanjay Kaul shared decision making SHARP trial statins Steve Nissen stroke Tamiflu Tom Jefferson Vioxx Vytorin Zetia
    • cardiology (37)
      • plant sterols (3)
    • conflicts of interest (2)
    • data sharing (6)
    • drug safety (14)
    • health care (10)
    • health care costs (3)
    • medical device safety (2)
    • nutrition (1)
    • politics (1)
    • scholarly journals (6)
    • shared decision making (3)
    • Uncategorized (10)
  • Blogroll

    • A New Merck: Reviewed
    • CardioBrief
    • e-Patient Dave
    • e-patients.net
    • Health Care Renewal
    • KER Unit Blog (Mayo Clinic)
    • MaxSpeak
    • Regina Holliday's Medical Advocacy Blog
    • Respectful Insolence
    • Science-Based Medicine
    • The Incidental Economist
    • To Conquer Confusion
  • Family

    • Sonya Ellen Mann
    • Sonya Supposedly
    • Virginia By Wrote
  • Links

    • Familial Hypercholesterolemia Discussion Group
    • The Walking Gallery of Healthcare

Blog at WordPress.com.

  • Comment
  • Reblog
  • Subscribe Subscribed
    • Marilyn Mann's Blog
    • Join 51 other subscribers
    • Already have a WordPress.com account? Log in now.
    • Marilyn Mann's Blog
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
%d